Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well said Dip.
jonny, seriously man... Just going back 1 year.
Taking into consideration the acceleration from Q2 2014 to the 10K 2014 was conversions from Merger. PXYN on average increases SS by 25M each quarter. Do the math yourself. The question I keep trying to get everyone to ask is, where do you think we'll be next year?:
Q2: The number of shares outstanding of the registrant’s common stock as August 12, 2015 was 625,079,157 shares.
Q1: The number of shares outstanding of the registrant’s common stock as May 15, 2015 was 603,970,157 shares.
10K: The number of shares outstanding of the registrant’s Common Stock as of April 10, 2015 was 577,107,157 shares.
Q3: The number of shares outstanding of the registrant’s common stock as November 19, 2014 was 421,189,263 shares.
Q2: The number of shares outstanding of the registrant’s common stock as August 19, 2014 was 343,954,384.
That's false and you shouldn't defend a company that doesn't do anything to prevent expansion of their share structure.
Anything less than a half-hearted buyback attempt will only depress the PPS further. PXYN needs to start buying shares off the open market in a substantial, and consistent way.
Share structure continues to increase.
Why not start there?
There's a notion that's perpetuated across the OTC that anything less than going all-in on an OTC company isn't a true measure of a long-term investor.
I argued this point awhile back. People see OTC companies like they do Football teams. There's fans; then there's real fans.
PXYN isn't an NFL team.
And going long on a company doesn't mean an investor or trader is required to go all-in under a do-or-die scenario.
Manage your money how you see fit and don't be ashamed to be cautious.
Volume grows inversely proportional to Price.
Going to take more than a press machine now. This is a classic case of a little too much, too late.
I've reorganized your question into a smaller, more meaningful reiteration:
Why?
I hope you don't mind.
I enjoyed your quote by the way.
Feel free to email them the list if you want; Ed's not a dummy though. He knows what he can do; he's just decided not to.
Ed has a range of tools he could use to establish confidence.
1. Buy some Common Shares, invest in his own company's future.
2. Buy Shares on the open market. PXYN should be able to afford $50K - $100K a quarter without impacting their balance sheet.
3. Quarterly Conference Calls.
4. Letter to Shareholders from the CEO.
5. Timely publication of Material Events that impact buying decisions.
6. Reduce the A/S. Even a Marginal reduction from 1.4B to 1.2B would help.
7. Publish a Shareholder Bill of Rights.
8. Bring in new Board Members outside of PXYN with connections to industry.
9. Publish their long-term strategy on how PXYN intends to increase shareholder value.
10. Consolidated Audit Trails.
11. Use social media more. Interact!
12. How about we just get the CEO to introduce himself to Shareholders? This still hasn't been done. Not a letter, not a Hello Folks, I'm Ed Kurtz ... not a peep. We got a PR notifying us of the change about 18 months ago.
Folks, some of these tools on this list take a bit of effort, but majority can be done today. It's not our responsibility to establish confidence. It's the CEO's.
Some of you are going to point to revenue as the measure of confidence, and my answer to you is: Price Per Share. Revenue is a measure of how well sales are performing. PPS is the measure of investor confidence. Not the topline on the balance sheet.
If he really wanted to establish confidence, he could do so today. But he chooses not to. There's only one question everyone needs to ask: Why?
1. with the exception of share structure and cash flow, everything else looks fine. it's a shame those two are arguably the most important elements in a fundamental valuation.
2. there's too many bagholders on PXYN now. Too much sell pressure baked into the L2. It'd take a mind altering business transaction, like PXYN being acquired by a F500 company to reverse the trend now ( we all know that isn't on the horizon anytime soon).
Only way to clear the air is a reset. Let's go ahead and hit rock bottom. Let's do it quickly; pull the bandaid off. Ed Kurtz isn't going to help anyone here. We can only help ourselves.
I've had shares in PXYN all but 2 days, of the last year and 1/2. I've been critical of Ed throughout most of that time.
I still have shares. I'm still critical of Ed.
But you can call me a pumper, or basher if it makes you feel better.
Ed's a manager. Not a leader; as demonstrated by the PPS.
Garbino would at least have the PPS up by now. The guy knows one thing; how to sell.
I've never said PXYN was a p&D. And I've flipped for a profit twice, and most recently, once for a loss. I'm long term on PXYN but I can recognize that my money is better placed on the sidelines while PXYN figures out what the heck they're doing.
Buying in on a QB company and holding no matter the development will earn you one thing: pain. Going long on a QB company takes finesse.
Revenue isn't the problem. It's the guy at the helm, determined to go down with his own ship. Ships fine. Driver needs to be replaced.
Basically the same stuff we've been wanting to see since last April 2014. This guy isn't delivering ...
NHS might spin up in Q3 but what do you think will get reflected in the Q?
Answer: a modest increase in top and bottom lines. If, NHS can get their sales mechanics straightened out. The QB is a momentum market, and it's hard to sustain momentum when there's a 5 month gap in reporting.
There's no more room this year for a "next Quarter..." Q3 is the last report for 2015.
Look guys, I'm not trying to be doom and gloom. But the reality is that the rest of 2015 looks pretty bleak. I'd like to see PXYN make it too. But Ed failed to deliver in a big way this year and I have zero confidence he can pull things around in the next 3 months. The guy just isn't that quick.
Next year maybe.. This year's a bust.
we'll start all over .004 - .008 next April.
Subpenny is inevitable. Ed Kurtz is leading this charge.
We have one rally point left in mid November with Q3; pending any miraculous news we then have a long stretch to the K next April. Contrary to what some suggest, any acquisition news at this point will inflate the A/S count. There is no free cash on hand for acquisitions. And at the rate NHS is failing to spin up, I doubt we see any sort of momentum for the remainder of this year. Ed's really screwed this up in a monumental way this year.
On Common Stock: I've said it before and I will say this again; Ed uses common stock like a cudgel and swings in one direction -down. There's no strategy, no vision, no method to value generation. Common stock is not a financial tool here; it's a payment method.
Folks, I strongly believe that subpenny is now our best chance to an authentic, organic recovery, but the slow stairstep down to .005 will not get us there. Ed will not get us there. Q3 will not get us there. Supporting the CEO's failures will not get us there. We need a fresh reset on PXYN. New money, new buyers. The only way we get them is to give them their value proposition on short-term forays into the .01's.
Wouldn't expect a move until November. PXYN's basically fumbled their entire FY15 calendar of releases, and this isn't the kind of CEO that's PR chatty. November Q3 is their last chance this fiscal year to bolster their claim that they are "improving shareholder value".
After that it's a looong stretch until the 15 April 10K and that gap is historically filled with silence from the company.
IMO Ed's made a complete mess of "improving shareholder value" this year. He really failed in a big way this Q.
Trust is tough to come by in the OTC.
The only place we can indefinitely sustain a trading volume of 5M - 10M per day is subpenny.
Ed appears quite content to ignore our demands to fix share structure. He's been ignoring this for about 12 months now, and the SS grows every quarter.
My guess is next quarter will show a similar trend. And the quarter beyond that.
It doesn't matter how much revenue PXYN pulls in if they can't manage their public stock.
I continue to assert that if you are a retail, then you should consider that this guy is not a CEO with your interests in mind.
He seems to cater only to preferred holders.
Uncertainty continues. Ed had a great chance to finally bring some clarity and direction to PXYN this quarter. Once again he fails and the price reflects his failure.
So what are u suggesting doc, that the pr's have been geared toward us? That Kurtz has been looking out for retail this entire time?
You make a really good point. So far I haven't seen a PR directed at retail. Everything's been tailored for preferred holders.
Eds doing his own thing trying to run a legitimate company. He's good in one area: general management. He's not CEO material but he drank the koolaid.
He needs to get out of everyones way and appoint a real CEO.
Preferreds are fine with him leading the way. If he succeeds, everyone's happy. If he fails, at least he provides them with an extended window to sell. Win/Win for that crowd.
Because I'm waiting on this to hit subpenny now. Ed will get us there. He's been nothing, if not reliable on supporting downward pressure.
Heh. So you think Ed is at such an elevated level that he doesn't pay attention to the only forum in existence that discusses daily, his company?
Of course they are. Aside from the soap opera effect we're having on their egos; not keeping tabs would just indicate further incompetence.
Corporate intelligence. Keep tabs on everyone.
Besides, ihub is the only source for current, public discussion; whether the info is right or wrong.
They're absolutely tracking the messages here.
I think if I waited for PXYN to play their hand I'd be old, broke and senile.
Ed is not the messiah. He fumbles every quarter and there's real concerns he's ignoring.
1. I want to see Share Structure reduced, or I want to hear of a plan. There's really no excuse here to remain silent. If the plan is long-term, then tell us it's long-term. If there's issues with cash flow, tell us there's issues with cash flow and that they'll get to share structure reduction when they can. Any halfway intelligent CEO can go on record to support his stock price without making irrational promises.
2. Cash Flow - Not even sure where to start now it's such a mess. Ed has reversed course and widened the deficit. One could argue that he intends to grow the company through debt -the problem is 1.) we don't know that because he doesn't tell his shareholders anything, and 2.) there's quite a few balance sheet items that need to be fixed first. Growth can come after the company turns healthy. Growing a company with cancer just grows the cancer. Fix the cancers first.
3. If you want your money to be taken seriously, Longs need to grab their attention. The divisiveness on the forums here works in favor of Ed and his policy of silence. If all the Longs start saying the same message, chances are that message would be heard and results would follow. PXYN has demonstrated that when complaints grow loud enough, they respond (begrudgingly).
And I'd like to see our dear CEO actually purchase a few common shares. I mean really... If the guy really cared about improving shareholder value, he'd spend a bit of his own cash and invest it into his companys future. I'd like to know why he hasn't purchased a single share.
it would kickstart interest. I suspect we're going to grow old waiting on Ed to grow some balls. I think he really let everyone down here this Q and I can't imagine how he sleeps at night for it.
So I'm fine with a steep dive into subpenny land if it'll attract new buyers and traders. This slow creep down will just continue to feed on itself. Let's get there now and see what happens.
The balance sheet is a tree in the forest. It's trending in the right direction, but still not healthy.
And they've done nothing to address cash flow and share structure. Ed seems to have turned a blind eye to the 2 issues that would really demonstrate health and stability.
I'm settling into the same opinion.
The issue is the on-average 25M shares per quarter that get introduced into the share pool every 90 days. With the exception of the Q3 2014 report and the following 10K (share structure expansions directly related to share conversions due to merger) every quarter post-merger has seen a share structure increase of approximately 25M.
It's unsustainable.
Unsustainable at the current price. Granted, I agree that fundamentals have improved also, however; not yet enough to attract large buyers who invest in fundamental growth. Part of the issue of attracting such buyers is share structure. It's part of Fundamentals.
.01 - .02 is still too pricy; we're unable to adequately absorb the additional shares and maintain price. Under current liquid conditions, we could probably handle 5M - 10M per quarter but 25M per quarter tilts the scale in favor of bears.
If PXYN is left to its usual devices (i.e., void of any support from PXYN management -which is typical), an additional 25M shares this quarter should see share price eventually trade around .01 or even go subpenny.
We need news and excitement to counter the slow drip. Something PXYN has so far been a stranger to.
I think .004 to .008 is a realistic trading level with forays in to the .01 - .02 range on news, given we continue to see selling pressure. At the subpenny level, more shares can be absorbed and traded until PXYN is ready and capable of actually supporting their public stock.
looks like mick and pete and co are loading up.
think they called the pincher play a little early but maybe it takes care of itself ...
I could throw that right back at you but I won't. Assumptions are the name of the game here. This is a speculative market and you're no different than anyone else posting here.
That said, my assumption is that PXYN is not going to sign a $120M contract for $50M in receivables. Doing so infers that PXYN is either grossly incompetent, or committing Fraud and Abuse.
Your assumption is exactly that. Gross incompetence, or Fraud. Let's call it like it is.
Just confirms we have no institutional interest. High risk would be the first thing to go.
PXYN cash on hand was notable only for the fact that they had on reserve enough cash to meet the August payments. Looks like Ed's been hoarding cash in anticipation of. NHS will need to hold up their end of the deal.
There's no real benefit to visiting PXYN unless I can come away with something -which PXYN will almost certainly not allow me to do.
I have in mind a request to conduct a pre-screened YouTube interview with Ed if he's willing but I haven't sent the request in.
Randy said it best: